Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01UKL
|
|||
Former ID |
DNC004371
|
|||
Drug Name |
S-(N-heptyl-N-hydroxycarbamoyl)glutathione
|
|||
Synonyms |
CHEMBL128836; S-(N-heptyl-N-hydroxycarbamoyl)glutathione; BDBM50092831
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H32N4O8S
|
|||
Canonical SMILES |
CCCCCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O
|
|||
InChI |
1S/C18H32N4O8S/c1-2-3-4-5-6-9-22(30)18(29)31-11-13(16(26)20-10-15(24)25)21-14(23)8-7-12(19)17(27)28/h12-13,30H,2-11,19H2,1H3,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t12-,13-/m0/s1
|
|||
InChIKey |
BRCVFVPDJZMQPO-STQMWFEESA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lactoylglutathione lyase (GLO1) | Target Info | Inhibitor | [1] |
BioCyc | Methylglyoxal degradation I | |||
KEGG Pathway | Pyruvate metabolism | |||
NetPath Pathway | TCR Signaling Pathway | |||
Pathwhiz Pathway | Pyruvaldehyde Degradation | |||
Pyruvate Metabolism | ||||
Reactome | Pyruvate metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I. J Med Chem. 2000 Oct 19;43(21):3981-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.